Pharmacokinetics of oxaliplatin in gastrointestinal cancer patients with malignant ascites

J Chemother. 2011 Feb;23(1):28-31. doi: 10.1179/joc.2011.23.1.28.

Abstract

The pharmacokinetics of oxaliplatin in plasma and ascitic fluid was investigated in 5 gastrointestinal cancer patients with malignant ascites. Oxaliplatin was administered at 85 mg/m² by 2-hour infusion in the FOLFOX4 regimen, and the concentrations of total and free platinum were measured. There was a trend of lower plasma C(max) values of total platinum in patients with a larger volume of ascitic fluid. The AUC(0-t) values of mean concentration curves of total plasma platinum, total ascites platinum, free plasma platinum, and free ascites platinum were 31.15, 7.96, 4.93 and 2.93 mg•h/ml, respectively. The concentrations of free ascites platinum were similar to those of free plasma platinum at the last sampling time of 26 h in each patient. The decrease or disappearance of ascitic fluid was observed in 4 patients. These results suggest that oxaliplatin exerted a beneficial effect in gastrointestinal cancer patients with malignant ascites, even when administered intravenously.

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / blood
  • Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics*
  • Area Under Curve
  • Ascites / blood
  • Ascites / metabolism
  • Ascites / pathology
  • Ascitic Fluid / metabolism
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / blood
  • Fluorouracil / pharmacokinetics
  • Gastrointestinal Neoplasms / blood
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / metabolism*
  • Gastrointestinal Neoplasms / pathology
  • Humans
  • Infusions, Intravenous
  • Leucovorin / administration & dosage
  • Leucovorin / blood
  • Leucovorin / pharmacokinetics
  • Male
  • Middle Aged
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / blood
  • Organoplatinum Compounds / pharmacokinetics*
  • Organoplatinum Compounds / therapeutic use
  • Oxaliplatin
  • Platinum / blood
  • Platinum / pharmacokinetics

Substances

  • Organoplatinum Compounds
  • Oxaliplatin
  • Platinum
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol